Patent: RE47636
✉ Email this page to a colleague
Summary for Patent: RE47636
Title: | Substituted spirocycles |
Abstract: | This invention relates to a compound of formula I ##STR00001## wherein A and Cy have one of the meanings as indicated in the specification and their use as inhibitors of Cathepsin C, pharmaceutical compositions containing the same and methods of using the same as agents for treatment and/or prevention of diseases connected with dipeptidyl peptidase I activity, e.g. respiratory diseases. |
Inventor(s): | Vintonyak; Viktor (Warthausen, DE), Grauert; Matthias (Biberach an der Riss, DE), Grundl; Marc (Biberach an der Riss, DE), Pautsch; Alexander (Biberach an der Riss, DE) |
Assignee: | Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) |
Application Number: | 15/827,433 |
Patent Claims: | see list of patent claims |
Details for Patent RE47636
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Jubilant Hollisterstier Llc | N/A | positive skin test control-histamine | Injection | 103891 | 03/13/1924 | ⤷ Try a Trial | 2034-09-12 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |